| Total (N = 30) | Type 2 GD (N = 11) | Age < 4 years (N = 6) | Treatment-naïve (N = 7) |
---|---|---|---|---|
Patients with ADRs, n (%) | 7 (23.3) | 7 (63.6) | 5 (83.3) | 2 (28.6) |
ADRs, n | 14 | 14 | 10 | 3 |
Patients with serious ADRs, n (%) | 5 (16.7) | 1 (9.1) | 1 (16.7) | 1 (14.3) |
Serious ADRs, n | 10 | 2 | 2 | 2 |
Type of ADR | Â | Â | Â | Â |
 Antibody test positive | 2 | 2 | 1 | 0 |
 Pyrexia | 2 | 2 | 2 | 1 |
 Vomiting | 2 | 2 | 1 | 0 |
 Aspartate aminotransferase increased | 1 | 1 | 1 | 0 |
 Erythema | 1 | 1 | 1 | 0 |
 Gastric hypomotility | 1 | 1 | 1 | 1 |
 Hyperchlorhydria | 1 | 1 | 1 | 1 |
 Myoclonus | 1 | 1 | 0 | 0 |
 Rash | 1 | 1 | 0 | 0 |
 Swelling of eyelid | 1 | 1 | 1 | 0 |
 Tachycardia | 1 | 1 | 1 | 0 |